reports
Sovereignty Wins the 151st Running of the Kentucky Derby Presented by ...
Sovereignty Wins the 151st Running of the Kentucky Derby Presented by Woodford Reserve New All-Time Handle Record Set for the Kentucky Derby Race, Kentucky Derby Day Program, and Kentucky Derby Week Races LOUISVILLE, Ky., May 03, 2025 (GLOBE NEWSWIRE) -- Churchill Downs Incorporated (Nasdaq: CHDN) (the "Company", "CDI", "we") announced today that Sovereignty claimed the Garland of Roses at the 151st running of the Kentucky Derby presented by Woodford Reserve under steady rain and the watchful eyes of over 147,000 eager racing fans. Sovereignty, owned and bred by Godolphin, LLC, traine...
- Steffen Evjen
TGS (Buy, TP: NOK110.00) - Exposed to spending cuts
We maintain our positive view on TGS; however, we have cut our 2025–2026e FCF by 20%, as we believe oil companies’ capex cuts could have a meaningful impact on seismic spending and TGS’s revenues. That said, near-term FCF should be supported by self-help elements from the PGS merger, and we find decent valuation support, with the stock trading at a ~15% FCF yield and ~9% dividend yield on 2025e. We reiterate our BUY, but have cut our target price to NOK110 (140).
Ölgerðin Egill Skallagrímsson hf.: Framboð til stjórnar
Ölgerðin Egill Skallagrímsson hf.: Framboð til stjórnar Aðalfundur Ölgerðarinnar Egill Skallagrímsson hf. verður haldinn fimmtudaginn 8. maí 2025, kl. 16:00, í höfuðstöðvum félagsins að Grjóthálsi 7-11 í Reykjavík. Framboðsfrestur til stjórnar rann út þann 3. maí 2025, kl. 16:00. Eftirtaldir einstaklingar hafa gefið kost á sér til setu í stjórn félagsins: Bogi Þór Siguroddsson Gerður Huld Arinbjarnardóttir Magnús Árnason Rannveig Eir Einarsdóttir Sigríður Elín Sigfúsdóttir Er það mat stjórnar að framboðin séu gild, sbr. 63. gr. a. hlutafélagalaga og samþykktir félagsins. Samkvæm...
IBA launches QUASAR® GRID3D Advantage Image Distortion Analysis System
IBA launches QUASAR® GRID3D Advantage Image Distortion Analysis System New standard in the Quality Assurance of image distortion for MR guided radiation therapy and MR simulation in planning Louvain-la-Neuve, Belgium, 3 May 2025 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and a global leading provider of dosimetry and quality assurance (QA) solutions, today announces the launch of its QUASAR® GRID3D Advantage Image Distortion Analysis System at the European Society for Radiotherapy and Oncology (ESTRO) 2025 Annual Congress in Vienna, Au...
IBA lance QUASAR® GRID3D Advantage, un système d'analyse de distorsion...
IBA lance QUASAR® GRID3D Advantage, un système d'analyse de distorsion d'image Nouvelle norme pour l'assurance qualité de la distorsion de l'image pour la radiothérapie guidée par résonnance magnétique et la simulation de plan de traitement Louvain-la-Neuve, Belgique, le 3 mai 2025 – IBA (Ion Beam Applications S.A., EURONEXT), le leader mondial des technologies d’accélération de particules et l'un des principaux fournisseurs de solutions de dosimétrie et d'assurance qualité (QA), annonce aujourd'hui le lancement de son système d’analyse de distorsion d’image QUASAR® GRID3D Advantage lors d...
ReGen III Corp: 1 director
A director at ReGen III Corp maiden bought 777,778 shares at 0.210CAD and the significance rating of the trade was 60/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years...
- ABGSC Capital Goods Research
- Anders Idborg
- Karl Bokvist
Haleon: 1 director
A director at Haleon maiden bought 15,424 shares at 401p and the significance rating of the trade was 57/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly show...
Alpine Select AG: 1 director
A director at Alpine Select AG bought 3,125 shares at 7.607CHF and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearl...
Constellation Software Inc: 1 director
A director at Constellation Software Inc sold 4,000 shares at 5,000.000CAD and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ...
Poulina Group Holding: 1 director
A director at Poulina Group Holding sold 706,487 shares at 14.004TND and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years...
Integer Holdings Corp: 1 director
A director at Integer Holdings Corp sold/gave away/sold after exercising options 362,975 shares at 0.000USD and the significance rating of the trade was 95/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the compa...
Macom Technology Solutions Holdings Inc: 1 director
A director at Macom Technology Solutions Holdings Inc sold 6,471 shares at 100.000USD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over th...
Sprouts Farmers Market Inc: 2 directors
Two Directors at Sprouts Farmers Market Inc sold 3,972 shares at between 173.000USD and 175.005USD. The significance rating of the trade was 58/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directo...
Williams Sonoma Inc: 1 director
A director at Williams Sonoma Inc sold 4,000 shares at 156.784USD and the significance rating of the trade was 64/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cle...
Molina Healthcare Inc: 1 director
A director at Molina Healthcare Inc sold 87,500 shares at 320.059USD and the significance rating of the trade was 74/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years ...
Unity Software Inc: 1 director
A director at Unity Software Inc sold 166,667 shares at 21.590USD and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cle...
PJT Partners Inc: 1 director
A director at PJT Partners Inc sold 5,000 shares at 141.740USD and the significance rating of the trade was 88/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearl...
Morgan Stanley: 2 directors
Two Directors at Morgan Stanley sold 40,800 shares at between 119.324USD and 119.995USD. The significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the...
Ionis Pharmaceuticals Inc: 1 director
A director at Ionis Pharmaceuticals Inc bought 15,000 shares at 31.860USD and the significance rating of the trade was 75/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two y...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.